Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.43 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10740141 | 1.00 | HTT (0.44) | HTTLMNAHDAC8HDAC6HDAC1 | |
| SCHEMBL11678689 | 1.00 | HTT (0.44) | HTTLMNAHDAC8HDAC6HDAC1 | |
| SCHEMBL3438249 | 0.98 | HDAC1 (0.46) | HTTLMNAHDAC8HDAC6HDAC1 | |
| SCHEMBL3243130 | 0.96 | ESR2 (0.46) | HTTLMNAHDAC8HDAC6HDAC1 | |
| SCHEMBL4453448 | 0.89 | KMT2A (0.39) | HTTLMNAHDAC8HDAC6HDAC1 | |
| SCHEMBL21752934 | 0.89 | HAO1 (0.48) | HTTLMNAHDAC8HDAC6HDAC1 | |
| SCHEMBL741455 | 0.89 | CYP2A6 (0.44) | ALDH1A1KDM4EESR2TRIM24TRIM33 | |
| SCHEMBL19218160 | 0.89 | CYP2A6 (0.44) | ALDH1A1KDM4EESR2TRIM24TRIM33 | |
| SCHEMBL21386555 | 0.83 | CYP3A4 (0.45) | SMN1; SMN2ALDH1A1KDM4EKMT2ATDP1 | |
| SCHEMBL2320728 | 0.83 | NPC1 (0.47) | ALDH1A1KDM4EKMT2ATDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 441 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101437784-B | 4- (4-alkylcyclohexyl) benzaldehyde | MITSUBISHI GAS CHEMICAL CO | 2013-08-28 | — | — | CN | claimed |
| EP-2017252-B1 | PREPARATION OF 4-(4-ALKYLCYCLOHEXYL)BENZALDEHYDE | MITSUBISHI GAS CHEMICAL CO (JP) | 2012-12-19 | — | — | EP | claimed |
| US-7777081-B2 | 4-(4-alkylcyclohexyl)benzaldehyde | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2010-08-17 | — | — | US | claimed |
| CN-101437784-A | 4- (4-alkylcyclohexyl) benzaldehyde | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-05-20 | — | — | CN | claimed |
| US-20090118547-A1 | 4-(4-ALKYLCYCLOHEXYL)BENZALDEHYDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-05-07 | — | — | US | claimed |
| EP-2017252-A1 | 4-(4-ALKYLCYCLOHEXYL)BENZALDEHYDE | Mitsubishi Gas Chemical Company, Inc. (JP) | 2009-01-21 | — | — | EP | claimed |
| US-20060058351-A1 | Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2006-03-16 | — | — | US | claimed |
| EP-1599447-A1 | LIGANDS THAT MODULATE LXR-TYPE RECEPTORS | Galderma Research & Development, S.N.C. (FR) | 2005-11-30 | — | — | EP | claimed |
| WO-2004076418-A1 | LIGANDS THAT MODULATE LXR-TYPE RECEPTORS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-09-10 | — | — | WO | claimed |
| EP-1189891-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-03-27 | — | — | EP | claimed |
| US-6362342-B1 | BIOSYNTHESIS; DRUG LIBRARIES | LION BIOSCIENCE AG (DE) | 2002-03-26 | — | — | US | claimed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | claimed |
| US-4582903-A | Synthesis of unsaturated hydantoins with an inexpensive catalyst | STAUFFER CHEMICAL COMPANY (US) | 1986-04-15 | — | — | US | claimed |
| US-4345072-A | Process for the production of 5-arylidene hydantoins (B) | DEGUSSA AG (DE) | 1982-08-17 | — | — | US | claimed |
| WO-2024189504-A1 | BROAD - SPECTRUM ANTI VIRAL COMPOUNDS | FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) | 2024-09-19 | — | — | WO | disclosed |
| CN-114423742-B | Benzotriazole-based compound, light absorber and resin composition | 三井化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-115947714-B | Synthesis method of photochemical caching agent | 上海泰辉生物科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-4000130-A | INDOLE DYES, POLYACRYLONITRILE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
| US-3966678-A | Maleic anhydride-polyaldimine prepolymers | RHONE-POULENC S.A. (FR) | 1976-06-29 | — | — | US | disclosed |
| US-3966801-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118547-A1 | 4-(4-ALKYLCYCLOHEXYL)BENZALDEHYDE | CYP4F3, AFF4, COXFA4 | HTT 1658/4885LMNA 1572/4885HDAC8 3742/4885 |
| US-20060058351-A1 | Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof | NR1H2, NR1H3, RXRG | HTT 3542/4885LMNA 1835/4885HDAC8 787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.